Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 314

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Detection of SARS Coronavirus in Patients with Suspected SARS

Open access
Chan, Kwok H., Poon, Leo L.L.M., Cheng, V.C.C., Guan, Yi, Hung, I.F.N., Kong, James, Yam, Loretta Y.C., Seto, Wing H., Yuen, Kwok Y., Peiris, Joseph S. Malik·2004·Emerging Infectious Diseases

Abstract

Cases of severe acute respiratory syndrome (SARS) were investigated for SARS coronavirus (SARS-CoV) through RNA tests, serologic response, and viral culture.Of 537 specimens from patients in whom SARS was clinically diagnosed, 332 (60%) had SARS-CoV RNA in one or more clinical specimens, compared with 1 (0.3%) of 332 samples from controls.Of 417 patients with clinical SARS from whom paired serum samples were available, 92% had an antibody response.Rates of viral RNA positivity increased progressively and peaked at day 11 after onset of illness.Although viral RNA remained detectable in respiratory secretions and stool and urine specimens for >30 days in some patients, virus could not be cultured after week 3 of illness.Nasopharyngeal aspirates, throat swabs, or sputum samples were the most useful clinical specimens in the first 5 days of illness, but later in the illness viral RNA could be detected more readily in stool specimens.I n early 2003, severe acute respiratory syndrome (SARS) was recognized as a newly emerging pneumonic disease (1-3).A proportion of patients have watery diarrhea, usually at a later stage of the illness, suggesting that the infection may not be confined to the respiratory tract (4).A novel coronavirus, designated as SARS coronavirus (SARS-CoV), was implicated as the causative agent (5-7), and the respiratory disease has been reproduced in a nonprimate animal model (8).Hong Kong was one of the regions most affected, with >1,700 patients.Specific laboratory tests to detect viral RNA and antibody responses (5) were used to establish a cause in patients suspected to have SARS.Although virologic results for small cohorts of patients have been reported (4,5,9), analysis of results of these first-generation tests in routine clinical practice has not been published previously.We report the correlation of results of reverse transcriptase polymerase chain reaction (RT-PCR) and immunofluorescent serologic testing for SARS-CoV in 1,048 cases investigated for SARS in the first 5 weeks after the first-generation diagnostic tests became available in Hong Kong. Methods PatientsIn the weeks after the first-generation viral diagnostic tests became available in Hong Kong, SARS-CoV diagnosis was carried out in three laboratories, one of which was the Department of Microbiology of Queen Mary Hospital (QMH).Results from specimens investigated at QMH laboratory from April 1 through May 3, 2003, and subsequent follow-up specimens are included in this analysis.Clinical specimens used for viral RNA detection included nasopharyngeal aspirates, throat and nose swabs, saliva, sputum, endotracheal aspirates, feces, and urine.Nasopharyngeal aspirates were collected into a mucus trap, and residual secretions in the catheter were sucked into the trap by aspirating 2 mL of virus transport medium.Swabs were collected into 2 mL of virus transport medium containing vancomycin (final concentration 100 µg/mL), amikacin (30 µg/mL), and nystatin (40 U/mL).Urine and feces were collected into specimen containers and submitted directly to the laboratory without the addition of transport medium.The case definition has been previously described (5,10).Patients were categorized on a clinical basis as "clinical SARS," "suspected SARS," and "not SARS" by the attending clinicians, depending on the response to antimicrobial therapy for bacterial pathogens (e.g., tazocin 2.25-4.5 g intravenously 6-8 h/d, or azithromycin 500 mg/d for 7-10/d), the clinical and radiologic evolution of the illness, history of contact with other patients with SARS, and an alternative diagnosis that fully explained the clinical findings.Fecal, throat swab, and serum specimens from controls were obtained for comparison.Fecal specimens from patients with diarrhea were anonymously tested for SARS-CoV RNA.Throat swab specimens were collected after informed consent from patients attending primary care Detection of SARS Coronavirus inPatients with Suspected SARS

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid1002.030610

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 314

Metadata

Authors
Chan, K. H., Poon, L. L. L. M., Cheng, V. C. C., Guan, Y., Hung, I. F. N., Kong, J., Yam, L. Y. C., Seto, W. H., Yuen, K. Y., & Peiris, J. S. M.
Venue
Emerging Infectious Diseases
Published
2004-02
Volume
10
Issue
2
Pages
294-299
ISSN
  • 1080-6040 (ISSN-L)
  • 1080-6059
OpenAlex
W2161315652
Cited by
314
References
16
FWCI
14.40
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Detection of SARS Coronavirus in Patients with Suspected SARS. https://app.cochat.ai/papers/10.3201/eid1002.030610
The paper
Chan, K. H., Poon, L. L. L. M., Cheng, V. C. C., Guan, Y., Hung, I. F. N., Kong, J., Yam, L. Y. C., Seto, W. H., Yuen, K. Y., & Peiris, J. S. M. (2004). Detection of SARS Coronavirus in Patients with Suspected SARS. Emerging Infectious Diseases. https://doi.org/10.3201/eid1002.030610

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.